Long COVID‑19 and pregnancy: A systematic review
Vasiliki Epameinondas Georgakopoulou1, Chrysoula Taskou2, Demetrios A Spandidos3
1Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Insights
Long COVID-19 significantly affects pregnant women, with symptoms like fatigue being common. Risk factors include severe acute infection and non-vaccination, impacting maternal and neonatal health.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Public Health
Background:
- Post-acute sequelae of SARS-CoV-2 infection, or Long COVID-19, is a growing concern in pregnant populations.
- Understanding its prevalence, risk factors, and outcomes is crucial for maternal health.
Purpose of the Study:
- To systematically review and synthesize current evidence on Long COVID-19 in pregnant women.
- To identify prevalence rates, associated risk factors, and clinical outcomes.
Main Methods:
- Systematic literature search in PubMed, Scopus, and Google Scholar (Jan 2020 - Oct 2024).
- Inclusion of studies on pregnant/postpartum women with COVID-19 followed for ≥4 weeks.
- Narrative synthesis of data from 13 studies (13,729 participants) due to heterogeneity.
Main Results:
- Prevalence of Long COVID-19 in pregnant women ranged widely from 9.3% to 93%.
- Most common symptoms include fatigue, cognitive dysfunction, respiratory issues, and psychological disturbances.
- Key risk factors identified: severe acute COVID-19, obesity, pre-existing mental health conditions, and non-vaccination.
Conclusions:
- Long COVID-19 is prevalent in pregnant women, presenting diverse symptoms and impacting maternal/neonatal outcomes (e.g., preterm birth).
- Severe acute infection and comorbidities increase risk and severity.
- Targeted follow-up and standardized definitions are needed for effective management and research.
Abstract:
The impact of post-acute sequelae of SARS-CoV-2 infection, or Long coronavirus disease 2019 (COVID-19), on pregnant women remains a growing concern. The present systematic review synthesizes current evidence on the prevalence, risk factors and clinical outcomes of Long COVID-19 in pregnant women to improve understanding of its burden and implications for maternal health. A systematic search was conducted in PubMed, Scopus and Google Scholar for studies published between January 2020 and October 2024. Eligible studies included pregnant or postpartum women diagnosed with COVID-19 and followed for at least four weeks post-infection. Data extraction and quality assessment were performed using standardized tools, and the findings were narratively synthesized due to heterogeneity in study designs and outcome measures. A total of 13 studies encompassing 13,729 participants were included. The prevalence of Long COVID-19 varied widely, ranging from 9.3-93%. The most reported symptoms included fatigue, cognitive dysfunction, respiratory symptoms and psychological disturbances, with fatigue being the most prevalent. Severe acute COVID-19, obesity, pre-existing mental health conditions, and non-vaccination were identified as key risk factors for developing Long COVID-19. Several studies reported that women with Long COVID-19 were at a higher risk for adverse maternal and neonatal outcomes, such as preterm birth and increased need for neonatal intensive care. The severity of acute infection and the presence of comorbidities significantly influenced the risk and severity of Long COVID-19. Long COVID-19 is a prevalent condition among pregnant women, with significant variability in reported prevalence rates. It is associated with a range of symptoms that can impact maternal health and pregnancy outcomes. The findings highlight the need for targeted follow-up and management strategies in this population. Standardized definitions and longitudinal studies are essential to further elucidate the long-term impact of COVID-19 during pregnancy.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Disorders of the Female Reproductive System
